StockWatch
·

Aryan Share and Stock Brokers Ltd Q4 FY26 Results

ARYANQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue-0.08206.2%25.3%
Total Income0.0297.2%101.3%
Expenditure0.2717.5%123.3%
PBT-0.25166.6%54.0%
Net Profit-0.48233.6%247.3%
OPM100.00%
NPM
EPS0.00100.0%100.0%
View full financials

Aryan Share: FY26 Revenue ₹99.17 Lakhs

25 May 2026 · 25 May, 6:02 pm

Summary

Aryan Share & Stock Brokers Limited reported a mixed financial performance for the period ended March 31, 2026. The company delivered a robust full-year profit of ₹182.06 lakh, a significant increase from ₹3.14 lakh in FY25, alongside substantial annual revenue growth to ₹99.17 lakh from ₹8.7 lakh. However, Q4 FY26 results were challenging, with the company posting a loss of ₹27.61 lakh, a notable decline from a profit of ₹13.71 lakh in Q4 FY25. The final quarter also saw negative revenue from operations at ₹7.87 lakh. The Board also formalized the appointment of M/s S Ramesh Kumar & Associates as Internal Auditors for the upcoming fiscal year, and prior to this, a MoU was entered into for the transfer of its share broking business.

Key Highlights

  1. 1

    Full-year Profit for the period for FY26 surged to ₹182.06 lakh, a remarkable increase from ₹3.14 lakh in FY25.

  2. 2

    Annual revenue from operations for FY26 showed substantial growth, reaching ₹99.17 lakh compared to ₹8.7 lakh in the previous fiscal year.

  3. 3

    In Q4 FY26, the company recorded a loss of ₹27.61 lakh for the quarter, a significant downturn from a profit of ₹13.71 lakh reported in Q4 FY25.

  4. 4

    Quarterly revenue from operations for Q4 FY26 was negative ₹7.87 lakh, a sharp decline from ₹628 lakh in the same quarter last year.

  5. 5

    Basic Earnings Per Share for the full year FY26 improved significantly to ₹6.07, from a negligible ₹0.00 in FY25.

  6. 6

    The Board approved the appointment of M/s S Ramesh Kumar & Associates as Internal Auditors for the Financial Year 2026-27.

Informational and educational content only. Not investment advice.